Abstract
This cohort study examines laboratory, clinical, and survival outcomes among patients with gastroenteropancreatic neuroendocrine tumors (NETs) treated with peptide receptor radionuclide therapy.
These are selected metrics from InCites Benchmarking & Analytics tool, related to this output
This output has contributed to the advancement of the following goals:
Source: InCites